TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904.

Matthew H Kulke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.